Jari Metso
About
Jari Metso is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism.
According to data from OpenAlex, Jari Metso has authored 103 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Surgery, 36 papers in Molecular Biology and 36 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jari Metso's work include Cholesterol and Lipid Metabolism (36 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (31 papers) and Lipoproteins and Cardiovascular Health (16 papers). Jari Metso is often cited by papers focused on Cholesterol and Lipid Metabolism (36 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (31 papers) and Lipoproteins and Cardiovascular Health (16 papers). Jari Metso collaborates with scholars based in Finland, United States and Spain. Jari Metso's co-authors include Matti Jauhiainen, Christian Ehnholm, Vesa M. Olkkonen, Pirkko J. Pussinen, Arie van Tol, Soile Blomqvist, R. Pahlman, Petri T. Kovanen, Matti Lukka and Miriam Lee‐Rueckert and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Circulation Research.
In The Last Decade
Jari Metso
100 papers receiving 3.2k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jari Metso Finland | 32 | 1.3k | 1.3k | 1.1k | 615 | 576 | 103 | 3.2k | ||
| Ronald Barbaras France | 30 | 1.4k 1.1× | 1.2k 0.9× | 1.2k 1.1× | 614 1.0× | 351 0.6× | 53 | 3.4k | ||
| Lita A. Freeman United States | 35 | 1.5k 1.1× | 783 0.6× | 1.3k 1.3× | 439 0.7× | 428 0.7× | 73 | 3.2k | ||
| Ross W. Milne Canada | 33 | 938 0.7× | 934 0.7× | 1.2k 1.2× | 440 0.7× | 388 0.7× | 69 | 3.2k | ||
| Mary G. Sorci‐Thomas United States | 38 | 1.8k 1.4× | 1.2k 0.9× | 1.8k 1.7× | 559 0.9× | 462 0.8× | 85 | 4.4k | ||
| Deneys R. van der Westhuyzen United States | 39 | 1.9k 1.4× | 855 0.7× | 1.7k 1.6× | 578 0.9× | 314 0.5× | 75 | 3.8k | ||
| Laurent O. Martinez France | 28 | 1.1k 0.8× | 411 0.3× | 1.6k 1.5× | 398 0.6× | 289 0.5× | 81 | 3.2k | ||
| Anne Hermanowski‐Vosatka United States | 27 | 628 0.5× | 901 0.7× | 1.2k 1.1× | 213 0.3× | 251 0.4× | 38 | 3.4k | ||
| Linda A. Gleaves United States | 35 | 869 0.7× | 262 0.2× | 1.1k 1.0× | 477 0.8× | 582 1.0× | 52 | 3.5k | ||
| Markku O. Pentikäinen Finland | 30 | 821 0.6× | 401 0.3× | 841 0.8× | 348 0.6× | 514 0.9× | 62 | 2.9k | ||
| Ivan Gerling United States | 34 | 1.2k 0.9× | 1.1k 0.8× | 1.1k 1.1× | 155 0.3× | 958 1.7× | 111 | 3.8k |
Countries citing papers authored by Jari Metso
Since
Specialization
Citations
This map shows the geographic impact of Jari Metso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jari Metso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jari Metso more than expected).
Fields of papers citing papers by Jari Metso
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jari Metso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jari Metso. The network helps show where Jari Metso may publish in the future.
Co-authorship network of co-authors of Jari Metso
This figure shows the co-authorship network connecting the top 25 collaborators of Jari Metso. A scholar is included among the top collaborators of Jari Metso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jari Metso. Jari Metso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Nissilä, Eija, Hanna Ruhanen, Martina B. Lorey, et al.. (2021). Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles. iScience. 24(6). 102535–102535.
2.
Pietiäinen, Milla, Anton Safer, Markku Lehto, et al.. (2020). Serum lipopolysaccharide neutralizing capacity in ischemic stroke. PLoS ONE. 15(2). e0228806–e0228806.
3.
Ruhanen, Hanna, P.A. Nidhina Haridas, Ilenia Minicocci, et al.. (2020). ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(7). 158679–158679.
4.
Farré, Núria, David Santos, Jari Metso, et al.. (2019). Human ApoA-I Overexpression Enhances Macrophage-Specific Reverse Cholesterol Transport but Fails to Prevent Inherited Diabesity in Mice. International Journal of Molecular Sciences. 20(3). 655–655.
5.
Zhang, Xian, Qin Huang, Xin Wang, et al.. (2019). Dietary cholesterol is essential to mast cell activation and associated obesity and diabetes in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(6). 1690–1700.
6.
Nissilä, Eija, Katarzyna Leskinen, Kok P. M. van Kessel, et al.. (2018). Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages. Frontiers in Immunology. 9. 2701–2701.
7.
Hellberg, Sanna, Suvi Sippola, Heidi Liljenbäck, et al.. (2017). Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [18F]FDG uptake in Ldlr−/−Apob mice. Atherosclerosis. 263. 369–376.
8.
Jauhiainen, Matti, Sakari Kakko, Jari Metso, et al.. (2017). Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari).
9.
Lövgren, Janita, Jari Metso, Tuomas Huovinen, et al.. (2016). Identification and analysis of anti-HDL scFv-antibodies obtained from phage display based synthetic antibody library. WOS.
10.
Lövgren, Janita, Jari Metso, Tuomas Huovinen, et al.. (2015). Identification and analysis of anti-HDL scFv-antibodies obtained from phage display based synthetic antibody library. Clinical Biochemistry. 49(6). 472–479.
11.
Badeau, Robert M., Jari Metso, Petri T. Kovanen, et al.. (2013). The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari).
12.
Robciuc, Marius R., Marianna Maranghi, Daniel J. Rader, et al.. (2013). Angptl3 Deficiency Is Associated With Increased Insulin Sensitivity, Lipoprotein Lipase Activity, and Decreased Serum Free Fatty Acids. Arteriosclerosis Thrombosis and Vascular Biology. 33(7). 1706–1713.
13.
Escolà‐Gil, Joan Carles, Josep Julve, Helena Quesada, et al.. (2013). Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(4). 691–697.
14.
Nguyen, Su Duy, Katariina Öörni, Miriam Lee‐Rueckert, et al.. (2012). Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells. Journal of Lipid Research. 53(10). 2115–2125.
15.
Biedzka-Sarek, Marta, Jari Metso, Taru Meri, et al.. (2011). Apolipoprotein A-I Exerts Bactericidal Activity against Yersinia enterocolitica Serotype O:3. Journal of Biological Chemistry. 286(44). 38211–38219.
16.
Robciuc, Marius R., Jari Metso, Anca V. Sima, Christian Ehnholm, & Matti Jauhiainen. (2010). Human apoA-I increases macrophage foam cell derived PLTP activity without affecting the PLTP mass. Lipids in Health and Disease. 9(1). 59–59.
17.
Saarela, Jani, Jari Metso, Wolfgang J. Schneider, & Matti Jauhiainen. (2009). Avian phospholipid transfer protein causes HDL conversion without affecting cholesterol efflux from macrophages. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari).
18.
Tuomainen, Anita M., Matti Jauhiainen, Petri T. Kovanen, et al.. (2007). Aggregatibacter actinomycetemcomitans induces MMP-9 expression and proatherogenic lipoprotein profile in apoE-deficient mice. Microbial Pathogenesis. 44(2). 111–117.
19.
Chen, Jie, et al.. (2007). Coating of open tubular capillaries with discoidal and spherical high‐density lipoprotein particles in electrochromatography. Electrophoresis. 28(13). 2267–2274.
20.
T, Oka, Takeshi Kujiraoka, Mayumi Ito, et al.. (2000). Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. Journal of Lipid Research. 41(10). 1651–1657.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ronald Barbaras Breakdown of academic impact, for papers by Lita A. Freeman Breakdown of academic impact, for papers by Ross W. Milne Breakdown of academic impact, for papers by Mary G. Sorci‐Thomas Breakdown of academic impact, for papers by Deneys R. van der Westhuyzen Breakdown of academic impact, for papers by Laurent O. Martinez Breakdown of academic impact, for papers by Anne Hermanowski‐Vosatka Breakdown of academic impact, for papers by Linda A. Gleaves Breakdown of academic impact, for papers by Markku O. Pentikäinen Breakdown of academic impact, for papers by Ivan Gerling